Literature DB >> 28585133

Therapeutic effects of curcumin nanoemulsions on prostate cancer.

Yan-Bin Guan1,2, Shu-Yao Zhou3, Yu-Qiong Zhang3, Jia-le Wang3, Yu-Dong Tian4, Yong-Yan Jia3,5, Yan-Jun Sun6,7.   

Abstract

The therapeutic potential of curcumin (Cur) is hampered by its poor aqueous solubility and low bioavailability. The aim of this study was to determine whether Cur nanoemulsions enhance the efficacy of Cur against prostate cancer cells and increase the oral absorption of Cur. Cur nanoemulsions were developed using the self-microemulsifying method and characterized by their morphology, droplet size and zeta potential. The results showed that the cytotoxicity and cell uptake were considerably increased with Cur nanoemulsions compared to free Cur. Cur nanoemulsions exhibited a significantly prolonged biological activity and demonstrated better therapeutic efficacy than free Cur, as assessed by apoptosis and cell cycle studies. In situ single-pass perfusion studies demonstrated higher effective permeability coefficient and absorption rate constant for Cur nanoemulsions than for free Cur. Our study suggested that Cur nanoemulsions can be used as an effective drug delivery system to enhance the anticancer effect and oral bioavailability of Cur.

Entities:  

Keywords:  anticancer efficacy; curcumin; nanoemulsion; oral absorption; prostate cancer

Mesh:

Substances:

Year:  2017        PMID: 28585133     DOI: 10.1007/s11596-017-1742-8

Source DB:  PubMed          Journal:  J Huazhong Univ Sci Technolog Med Sci        ISSN: 1672-0733


  29 in total

Review 1.  Curcumin nanoformulations: a future nanomedicine for cancer.

Authors:  Murali M Yallapu; Meena Jaggi; Subhash C Chauhan
Journal:  Drug Discov Today       Date:  2011-09-18       Impact factor: 7.851

2.  Stability of curcumin in buffer solutions and characterization of its degradation products.

Authors:  Y J Wang; M H Pan; A L Cheng; L I Lin; Y S Ho; C Y Hsieh; J K Lin
Journal:  J Pharm Biomed Anal       Date:  1997-08       Impact factor: 3.935

3.  Curcumin inhibits growth of prostate carcinoma via miR-208-mediated CDKN1A activation.

Authors:  Hui Guo; Yuemin Xu; Qiang Fu
Journal:  Tumour Biol       Date:  2015-06-02

4.  Induction with NCB-02 (curcumin) enema for mild-to-moderate distal ulcerative colitis - a randomized, placebo-controlled, pilot study.

Authors:  Vikas Singla; Venigalla Pratap Mouli; Sushil Kumar Garg; Tarun Rai; Bikash Narayan Choudhury; Prashant Verma; Rachana Deb; Veena Tiwari; Sarika Rohatgi; Rajan Dhingra; Saurabh Kedia; Piyush Kumar Sharma; Govind Makharia; Vineet Ahuja
Journal:  J Crohns Colitis       Date:  2013-09-05       Impact factor: 9.071

Review 5.  Curcumin nanoformulations: a review of pharmaceutical properties and preclinical studies and clinical data related to cancer treatment.

Authors:  Ornchuma Naksuriya; Siriporn Okonogi; Raymond M Schiffelers; Wim E Hennink
Journal:  Biomaterials       Date:  2014-01-15       Impact factor: 12.479

6.  Preparation of curcumin microemulsions with food-grade soybean oil/lecithin and their cytotoxicity on the HepG2 cell line.

Authors:  Chuan-Chuan Lin; Hung-Yin Lin; Ming-Hung Chi; Chin-Min Shen; Hwan-Wen Chen; Wen-Jen Yang; Mei-Hwa Lee
Journal:  Food Chem       Date:  2014-01-14       Impact factor: 7.514

Review 7.  Advances in clinical study of curcumin.

Authors:  Chunfen Yang; Xun Su; Anchang Liu; Lin Zhang; Aihua Yu; Yanwei Xi; Guangxi Zhai
Journal:  Curr Pharm Des       Date:  2013       Impact factor: 3.116

8.  Chemopreventive potential of curcumin in prostate cancer.

Authors:  Marie-Hélène Teiten; François Gaascht; Serge Eifes; Mario Dicato; Marc Diederich
Journal:  Genes Nutr       Date:  2009-10-06       Impact factor: 5.523

9.  Polymeric nanoparticle-encapsulated curcumin ("nanocurcumin"): a novel strategy for human cancer therapy.

Authors:  Savita Bisht; Georg Feldmann; Sheetal Soni; Rajani Ravi; Collins Karikar; Amarnath Maitra; Anirban Maitra
Journal:  J Nanobiotechnology       Date:  2007-04-17       Impact factor: 10.435

10.  Novel self-nanoemulsifying formulation of quercetin: Implications of pro-oxidant activity on the anticancer efficacy.

Authors:  Amit K Jain; Kaushik Thanki; Sanyog Jain
Journal:  Nanomedicine       Date:  2014-01-07       Impact factor: 5.307

View more
  3 in total

Review 1.  Nanotechnology-Based Drug Delivery to Improve the Therapeutic Benefits of NRF2 Modulators in Cancer Therapy.

Authors:  Zerrin Sezgin-Bayindir; Sonia Losada-Barreiro; Carlos Bravo-Díaz; Matej Sova; Julijana Kristl; Luciano Saso
Journal:  Antioxidants (Basel)       Date:  2021-04-27

2.  Encapsulation of Gold Nanostructures and Oil-in-Water Nanocarriers in Microgels with Biomedical Potential.

Authors:  Mariela Inostroza-Riquelme; Andrea Vivanco; Pablo Lara; Simón Guerrero; Edison Salas-Huenuleo; Alejandro Chamorro; Lisette Leyton; Karen Bolaños; Eyleen Araya; Andrew F G Quest; Marcelo J Kogan; Felipe Oyarzun-Ampuero
Journal:  Molecules       Date:  2018-05-18       Impact factor: 4.411

3.  Bioactivity of Curcumin on the Cytochrome P450 Enzymes of the Steroidogenic Pathway.

Authors:  Patricia Rodríguez Castaño; Shaheena Parween; Amit V Pandey
Journal:  Int J Mol Sci       Date:  2019-09-17       Impact factor: 5.923

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.